---
title: "cTBS to a Somatosensory Lesion Network in Cervical Dystonia: Randomized Sham-Controlled Pilot"
id: "medrxiv-10-continuous-theta-burst-stimulation-to-a-lesion-network-in-cervical-dystonia-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-10-continuous-theta-burst-stimulation-to-a-lesion-network-in-cervical-dystonia-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.10.26362783v1?rss=1"
published_at: "2026-09-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# cTBS to a Somatosensory Lesion Network in Cervical Dystonia: Randomized Sham-Controlled Pilot
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-10-continuous-theta-burst-stimulation-to-a-lesion-network-in-cervical-dystonia-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.10.26362783v1?rss=1)
- **Published At:** 2026-09-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Background: The mechanisms underlying **cervical dystonia** are incompletely understood. Lesion network mapping identified a network with a hub in the **somatosensory cortex (S1)** as a potential noninvasive stimulation target. - Objective: Test whether modulating the S1 lesion network hub with **continuous theta-burst stimulation (cTBS)** reduces cervical dystonia symptoms in a randomized, double-blind, sham-controlled, crossover pilot trial. - Design and participants: Thirteen patients with idiopathic cervical dystonia (mean age 57.85 ± 10.85 years) received two counterbalanced 10-session blocks of bilateral S1 cTBS (active or sham) in a crossover design. - Primary outcome: Change in dystonia severity measured by the **Toronto Western Spasmodic Torticollis Scale (TWSTRS)**. Additional objective assessment used a wearable motion sensor to track head and neck movement patterns. - Neurophysiology and imaging: Motor evoked potentials assessed corticospinal excitability; resting-state fMRI evaluated functional connectivity changes after stimulation. - Main clinical result: Active cTBS did not produce a statistically significant reduction in TWSTRS scores compared with sham (condition × timepoint interaction: p = .149). - Secondary clinical result: **Range of motion** of head/neck increased significantly with active versus sham cTBS (p = .015) as measured objectively. - Physiology and imaging findings: Corticospinal excitability decreased following sham (p = .042) but not after active cTBS. No significant connectivity changes were detected from the S1 stimulation site after active cTBS; significant connectivity changes were observed originating from the **globus pallidus interna (GPi)**. - Safety and tolerability: The intervention was well tolerated by all participants. - Interpretation: Targeting a lesion-network-derived S1 hub with the tested cTBS protocol did not significantly improve primary clinical scores. The authors suggest future work could explore higher-dose or alternative neuromodulation protocols to this target. - Transparency: Trial registered (ACTRN12621000417886). Deidentified data are available on OpenNeuro and the Big NIBS repository; funding and competing interests are reported in the manuscript.
## Clinical Analysis & Structured Key Points
Continuous theta-burst stimulation to a lesion network in cervical dystonia: a randomized, double-blind, sham-controlled, pilot trial | medRxiv Skip to main content Continuous theta-burst stimulation to a lesion network in cervical dystonia: a randomized, double-blind, sham-controlled, pilot trial View ORCID Profile Jordan Morrison-Ham , Ellen F. P. Younger , Elizabeth G. Ellis , Nicholas Parsons , Thomas Hart , Bridgette Speranza , Lillian Dipnall , Michael Do , Ruben Perellon-Alfónso , Pasquale Maria Pecoraro , Lazzaro di Biase , Kelly L. Bertram , Paul A. Aguis , Francesca Morgante , Juho Joutsa , Aron T. Hill , Peter G. Enticott , Daniel T. Corp doi: https://doi.org/10.64898/2026.09.10.26362783 Jordan Morrison-Ham 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jordan Morrison-Ham For correspondence: jordan.morrison-ham{at}monash.edu Ellen F. P. Younger 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elizabeth G. Ellis 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nicholas Parsons 2 Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas Hart 3 Neurosciences and Cell Biology Institute, Neuromodulation and Motor Control Section, City St George's University of London, London, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bridgette Speranza 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Lillian Dipnall 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Michael Do 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ruben Perellon-Alfónso 4 Institute of Neurosciences, University of Barcelona, Barcelona, Spain; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Pasquale Maria Pecoraro 5 Research Unit of Neurology, Neurophysiology and Psychiatry, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Lazzaro di Biase 5 Research Unit of Neurology, Neurophysiology and Psychiatry, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kelly L. Bertram 6 Alfred Brain, Alfred Hospital, Bayside Health, Commercial Road, Melbourne; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Paul A. Aguis 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Francesca Morgante 3 Neurosciences and Cell Biology Institute, Neuromodulation and Motor Control Section, City St George's University of London, London, UK; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Juho Joutsa 7 Turku Brain and Mind Center, Clinical Neurosciences, University of Turku, Turku, Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aron T. Hill 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Peter G. Enticott 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel T. Corp 1 Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: The mechanisms driving cervical dystonia remain unclear, limiting effective, non-invasive treatment development. Lesion network mapping previously localized a brain network derived from lesions causing cervical dystonia, with a network hub in the somatosensory cortex, a viable target for non-invasive brain stimulation. Objectives: We conducted a randomized, sham-controlled, crossover trial administering continuous theta-burst stimulation (cTBS) to the S1 lesion network hub, testing whether modulating this network reduces CD symptoms. Methods: Thirteen idiopathic cervical dystonia patients (57.85 ± 10.85 years) received two 10-session blocks of bilateral somatosensory cortex cTBS (active or sham; counterbalanced). The primary outcome was change in cervical dystonia symptoms, measured by the Toronto Western Spasmodic Torticollis Scale (TWSTRS). A wearable motion sensor objectively measured change in head and neck movement patterns. Motor evoked potentials and resting-state fMRI assessed cTBS-induced changes in corticospinal excitability and functional connectivity, respectively. Results: Active cTBS did not significantly reduce cervical dystonia symptoms compared to sham (condition x timepoint interaction: p = .149). Range of motion significantly increased with active, versus sham, cTBS (p = .015). Corticospinal excitability decreased following sham (p = .042), but not active, cTBS. No significant connectivity changes were seen from the somatosensory cortex stimulation site after active cTBS; however, significant changes emerged from the globus pallidus interna. Conclusion: This study prospectively tested the effects of neuromodulation on a lesion network mapping-derived target. Active cTBS did not significantly improve TWSTRS scores relative to sham. The intervention was well tolerated by all patients, and future studies could consider higher-dose or alternative protocols to this target. Competing Interest Statement J.M-H. was supported by an Australian Government Research Training Program Scholarship and a PhD top-up grant from the Dystonia Network of Australia. E.F.P.Y and E.G.E. were supported by Deakin University Postgraduate Research Scholarships. E.G.E. was supported by a personal grant from the Sigrid Juselius foundation. F.M. has received speaking honoraria from Medtronic, Boston Scientific, Teva, Bial, Abbvie, Merz, Ipsen. She has been part of advisory boards of Medtronic, Boston Scientific, Bial, Abbvie. She receives Royalties from Springer. F.M. has received financial support for lectures from the International Parkinson and Movement Disorders Society. F.M. is an associate editor of Movement Disorders Journal. D.T.C. has received speaking honoraria from the Movement Disorders Congress (2025) and Dystonia Brain Stimulation meeting (2025). D.T.C. is supported by the Dystonia Medical Research Foundation under award number DMRF-BCAD-2023-1 and the European Unions Horizon 2023 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 101150147. Clinical Trial Australian New Zealand Clinical Trials Registry: ACTRN12621000417886 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: All study procedures were approved by the Deakin University Human Research Ethics Committee (DUHREC 2021-136) and were conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent to participate in the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The deidentified data that support the findings of this study are available at the Big NIBS data repository and OpenNeuro. https://openneuro.org/datasets/ds008174 https://bignibsdata.com Funder Information Declared Dystonia Coalition , NS065701 , TR001456 , NS116025 Dystonia Network of Australia Horizon Europe: Marie Skłodowska-Curie Actions , 101150147 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 12, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Continuous theta-burst stimulation to a lesion network in cervical dystonia: a randomized, double-blind, sham-controlled, pilot trial Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Continuous theta-burst stimulation to a lesion network in cervical dystonia: a randomized, double-blind, sham-controlled, pilot trial Jordan Morrison-Ham , Ellen F. P. Younger , Elizabeth G. Ellis , Nicholas Parsons , Thomas Hart , Bridgette Speranza , Lillian Dipnall , Michael Do , Ruben Perellon-Alfónso , Pasquale Maria Pecoraro , Lazzaro di Biase , Kelly L. Bertram , Paul A. Aguis , Francesca Morgante , Juho Joutsa , Aron T. Hill , Peter G. Enticott , Daniel T. Corp medRxiv 2026.09.10.26362783; doi: https://doi.org/10.64898/2026.09.10.26362783 Share This Article: Copy Citation Tools Continuous theta-burst stimulation to a lesion network in cervical dystonia: a randomized, double-blind, sham-controlled, pilot trial Jordan Morrison-Ham , Ellen F. P. Younger , Elizabeth G. Ellis , Nicholas Parsons , Thomas Hart , Bridgette Speranza , Lillian Dipnall , Michael Do , Ruben Perellon-Alfónso , Pasquale Maria Pecoraro , Lazzaro di Biase , Kelly L. Bertram , Paul A. Aguis , Francesca Morgante , Juho Joutsa , Aron T. Hill , Peter G. Enticott , Daniel T. Corp medRxiv 2026.09.10.26362783; doi: https://doi.org/10.64898/2026.09.10.26362783 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Neurology Subject Areas All Articles Addiction Medicine (617) Allergy and Immunology (899) Anesthesia (330) Cardiovascular Medicine (4804) Dentistry and Oral Medicine (478) Dermatology (414) Emergency Medicine (648) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1625) Epidemiology (15924) Forensic Medicine (32) Gastroenterology (1202) Genetic and Genomic Medicine (7037) Geriatric Medicine (732) Health Economics (1064) Health Informatics (5032) Health Policy (1432) Health Systems and Quality Improvement (1757) Hematology (584) HIV/AIDS (1343) Infectious Diseases (except HIV/AIDS) (16282) Intensive Care and Critical Care Medicine (1170) Medical Education (667) Medical Ethics (153) Nephrology (722) Neurology (7260) Nursing (366) Nutrition (1080) Obstetrics and Gynecology (1240) Occupational and Environmental Health (1004) Oncology (3600) Ophthalmology (1049) Orthopedics (397) Otolaryngology (451) Pain Medicine (470) Palliative Medicine (139) Pathology (706) Pediatrics (1795) Pharmacology and Therapeutics (737) Primary Care Research (765) Psychiatry and Clinical Psychology (5886) Public and Global Health (9742) Radiology and Imaging (2412) Rehabilitation Medicine and Physical Therapy (1448) Respiratory Medicine (1247) Rheumatology (640) Sexual and Reproductive Health (771) Sports Medicine (578) Surgery (775) Toxicology (107) Transplantation (304) Urology (290)
## Related Clinical Research

- [More REM (dream) sleep linked to lower risk of 83 diseases—UK Biobank study](https://medichelpline.com/clinical-feed/medical-news-today-0-more-dream-sleep-linked-to-lower-risk-of-83-diseases-including-diabetes.md)
- [Startup to test psychedelic-like drug for Parkinson’s apathy — STAT+ report](https://medichelpline.com/clinical-feed/stat-news-0-stat-new-startup-to-test-psychedelic-like-drug-against-parkinson-s-symptom.md)
- [Lysosomal polygenic risk score (lyso-PRS) and Parkinson’s disease risk across populations](https://medichelpline.com/clinical-feed/medrxiv-17-lysosomal-polygenic-risk-score-in-parkinson-s-disease-across-populations.md)
- [Adapted Tango Leaders vs Followers: Distinct Neural Paths to Motor Improvement in Parkinson's Dise](https://medichelpline.com/clinical-feed/medrxiv-8-leader-and-follower-roles-in-adapted-tango-reveal-complementary-neural-routes.md)
- [Carbon monoxide exposure may explain lower Parkinson's risk linked to smoking](https://medichelpline.com/clinical-feed/medical-news-today-0-why-smokers-may-have-a-lower-parkinson-s-risk-it-s-not-the-nicotine.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.